Narrowing of the blood vessels in the brain can result from a surprisingly long list of causes, ranging from the slow buildup of fatty plaques over decades to sudden spasms triggered by a single dose of a drug. The most familiar culprit is atherosclerosis, but infections, autoimmune inflammation, rare genetic conditions, and even mechanical compression of arteries by bone can all restrict blood flow to the brain. Understanding which mechanism is at work matters because each one carries different risks and calls for different treatment.
Atherosclerosis and Plaque Buildup
Atherosclerosis is the leading cause of narrowed brain arteries worldwide. The process is the same one that clogs coronary arteries: cholesterol-rich plaques accumulate inside the vessel wall, gradually shrinking the channel through which blood flows. In the brain, this tends to strike the large arteries at the base of the skull and along the circle of Willis. The contribution of intracranial atherosclerotic stenosis to stroke varies dramatically by population. In North America, it accounts for roughly 8 to 10 percent of ischemic strokes, while in East Asian populations it may be responsible for 30 to 50 percent of strokes and more than half of transient ischemic attacks.1PubMed. Prevalence of intracranial large artery stenosis and occlusion in patients with acute ischaemic stroke or TIA
The usual risk factors apply: high blood pressure, elevated cholesterol, diabetes, smoking, and aging. When a plaque grows large enough, it can either choke off blood flow directly or rupture and trigger a clot that blocks the artery entirely. Patients with symptomatic stenosis who also have impaired blood-flow reserve face especially steep danger. In one study, people with recently symptomatic high-grade carotid stenosis and exhausted cerebrovascular reactivity had a stroke rate of about 27 percent per month, compared with roughly 5 percent per month in those whose blood-flow reserve was intact.2Stroke. Risk of Stroke, Transient Ischemic Attack, and Vessel Occlusion Before Endarterectomy in Patients With Symptomatic Severe Carotid Stenosis
High Blood Pressure and Small Vessel Disease
Chronic high blood pressure damages brain arteries from the inside out, but it mainly targets the smallest ones: the tiny arterioles and capillaries deep within the brain’s white matter. Over years of elevated pressure, the walls of these vessels thicken, the blood-brain barrier weakens, and chronic low-grade ischemia sets in.3PubMed Central. Hypertension and Cerebral Small Vessel Disease: A Review of the Pathophysiology, Progression, and Prevention Unlike large-vessel atherosclerosis, which can cause a sudden stroke by blocking a major artery, small vessel disease tends to produce a creeping accumulation of brain injury. On MRI scans, it shows up as white matter lesions, tiny silent strokes, and microbleeds. Over time this contributes to cognitive decline and vascular dementia.
A key piece of the underlying biology involves nitric oxide, a molecule produced by the cells lining blood vessels. Nitric oxide keeps arteries relaxed and open. In conditions like hypertension and high cholesterol, nitric oxide production drops, and vessels lose some of their ability to stay properly dilated.4Clinical Science. Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention Animal studies have confirmed that when the nitric oxide system is impaired, cerebral blood flow regulation suffers.5PubMed Central. Role of endothelial nitric oxide in cerebrovascular regulation
Reversible Cerebral Vasoconstriction Syndrome
Not all narrowing is permanent. Reversible cerebral vasoconstriction syndrome (RCVS) is a condition in which brain arteries suddenly clamp down in widespread segments, dramatically reducing blood flow. The hallmark symptom is a thunderclap headache, an excruciating headache that peaks within seconds. By definition, the vasoconstriction resolves within about three months, and imaging eventually shows the arteries have returned to normal caliber.6Headache: The Journal of Head and Face Pain. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache
The diagnosis can be tricky because not everyone presents with the classic thunderclap pattern. Some patients develop a single severe headache, a mild or gradually worsening headache, or even no headache at all, instead showing up with seizures, confusion, or neurological deficits from a stroke.6Headache: The Journal of Head and Face Pain. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache And while the vasoconstriction itself is temporary, the stroke it can trigger is not. Stroke is the major complication of RCVS and can leave lasting disability.
RCVS is thought to stem from a temporary loss of control over cerebrovascular tone. More than half of cases follow exposure to certain drugs or the postpartum period.7PubMed. Reversible cerebral vasoconstriction syndrome
Drugs and Substances That Trigger Vasoconstriction
A wide range of substances can provoke narrowing of brain arteries, and the list goes well beyond illegal drugs. An analysis of 139 RCVS cases found that triggers included prescription medications like triptans (used for migraine) and selective serotonin reuptake inhibitors, over-the-counter decongestants containing pseudoephedrine, herbal supplements and diet pills with amphetamine-like compounds, and illicit drugs including cocaine and ecstasy.8JAMA Neurology. Reversible Cerebral Vasoconstriction Syndromes: Analysis of 139 Cases
Serotonin-boosting drugs deserve particular attention because they are so widely used. Case series have shown that serotonergic medications can precipitate a cerebrovascular syndrome of reversible, multifocal arterial narrowing even in people who have taken these drugs safely for some time.9PubMed. Cerebral vasoconstriction and stroke after use of serotonergic drugs That does not mean everyone on an antidepressant is at imminent risk; the complication is rare. But if you develop a severe sudden headache while taking one of these medications, it is worth mentioning the drug to your doctor.
Vasospasm After a Brain Bleed
When an aneurysm in the brain ruptures, blood spills into the subarachnoid space, the fluid-filled area surrounding the brain. In the days that follow, the arteries bathed in that leaked blood often go into spasm, sometimes severely enough to cause a second stroke on top of the original bleed. This delayed vasospasm typically peaks around a week after the hemorrhage and is one of the most feared complications of aneurysmal subarachnoid hemorrhage. The breakdown products of the pooled blood appear to irritate the vessel walls through both direct and indirect pathways, driving the arteries to constrict.10Journal of Neuroscience Research. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanisms and novel approaches
Moyamoya Disease
Moyamoya disease is a rare condition in which the terminal portions of the internal carotid arteries, the major vessels supplying the front of the brain, slowly narrow and eventually close off. The name comes from the Japanese word for “puff of smoke,” describing the hazy cloud of tiny collateral vessels that the brain grows in a desperate attempt to reroute blood supply around the blockage.11PubMed. Moyamoya disease: a summary These fragile collaterals are not adequate substitutes for the normal arteries, so patients remain at risk for ischemic strokes and, paradoxically, hemorrhagic strokes when the tiny vessels burst.
Moyamoya can occur in isolation (primary disease) or alongside other conditions like sickle cell disease, Down syndrome, or neurofibromatosis (sometimes called moyamoya syndrome). In sickle cell disease, large vessel vasculopathy resembling moyamoya significantly raises stroke risk.12PubMed Central. Cerebral Oxygen Metabolic Stress in Children and Adults With Large Vessel Vasculopathy Due to Sickle Cell Disease
The genetic basis has become clearer in recent years. A gene called RNF213 is the major susceptibility gene in East Asian populations, with the Arg4810Lys variant most strongly associated. But the penetrance is less than one percent, meaning most carriers never develop the disease, and additional genetic or environmental triggers seem necessary to push the process forward.13The Lancet Neurology. Advances in the pathophysiology, diagnosis, and treatment of moyamoya disease
Inflammation of Brain Arteries
Vasculitis, or inflammation of the blood vessel wall, can narrow or destroy brain arteries from within. Primary angiitis of the central nervous system (PACNS) is a rare form that strikes only the brain and spinal cord, affecting both medium and small vessels.14PubMed Central. Diagnosis and treatment of cerebral vasculitis It is diagnostically challenging because no blood test reliably identifies it, and the symptoms, including headache, cognitive decline, and stroke, overlap with many other conditions.15PubMed. Primary central nervous system vasculitis: pathology and mechanisms In children, small-vessel PACNS can be particularly difficult to pin down, sometimes requiring brain biopsy for a definitive diagnosis.16PubMed Central. Towards a histological diagnosis of childhood small vessel CNS vasculitis
Brain vasculitis can also occur as part of a systemic autoimmune disease. Systemic lupus erythematosus (SLE) is one notable example. In some patients with lupus, cerebral arteries develop inflammation and narrowing that can produce strokes. The narrowing can initially be mistaken for atherosclerosis, especially in older patients with typical cardiovascular risk factors. Specialized vessel wall MRI showing enhancement of the arterial walls can help clinicians distinguish inflammatory narrowing from plaque-based narrowing.17PubMed Central. A case of systemic lupus erythematosus associated with cerebral arteritis: a case report and case-based literature review Once correctly identified, lupus-associated cerebral vasculitis can respond to aggressive immunosuppressive treatment.18Lupus. Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide
Infections That Damage Brain Arteries
Certain infections can attack brain blood vessels directly. The best-documented example is varicella zoster virus (VZV), the same virus that causes chickenpox and shingles. After an initial infection in childhood, the virus lies dormant in nerve cells. When it reactivates, usually decades later, it can spread along nerve fibers into the walls of cerebral arteries, triggering vasculitis and stroke.19PubMed Central. Varicella Zoster Virus Vasculitis and Adult Cerebrovascular Disease VZV vasculopathy can affect both large and small cerebral arteries and does not always come with the telltale shingles rash, which makes it easy to miss.20PubMed Central. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features
Other infections, including HIV, syphilis, tuberculosis, and certain fungal infections, can also inflame brain arteries either through direct invasion or through the immune response they provoke. Because infection-driven vasculitis is treatable if caught, clinicians investigating unexplained stroke in a younger patient will often screen for infectious causes.
Hereditary Conditions and Genetic Arteriopathies
Some people are born with a genetic predisposition to progressive narrowing of brain arteries. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common hereditary form of cerebral small vessel disease. It results from mutations in the NOTCH3 gene and causes a distinctive non-atherosclerotic thickening of small and medium penetrating arteries in the brain. Patients typically develop migraines with aura, recurrent small strokes, mood disturbances, and progressive cognitive decline, often beginning in their 30s or 40s.21PubMed Central. CADASIL: A NOTCH3-associated cerebral small vessel disease
Fibromuscular dysplasia (FMD) is another non-atherosclerotic arteriopathy that can affect the arteries supplying the brain. FMD is a rare condition causing segmental, non-inflammatory narrowing of medium-sized arteries. When it involves the extracranial carotid or vertebral arteries, it can lead to artery dissection or aneurysm formation, both of which threaten brain blood supply.22PubMed Central. Cerebrovascular Fibromuscular Dysplasia – A Practical Review
Less Common Mechanical and Iatrogenic Causes
The vertebral arteries, which run up through small bony canals in the cervical spine, can be physically compressed by bone spurs or abnormal bony anatomy. This mechanical compression can produce stenosis of the vertebral artery, sometimes worsened by certain neck positions.23PubMed Central. Vertebral Artery Stenosis: A Narrative Review
Radiation therapy directed at brain or skull base tumors can also injure cerebral arteries years after treatment. In one pediatric study, the three-year cumulative rate of any radiation-related vasculopathy was about 6 percent, with serious vasculopathy (including transient ischemic attacks and strokes) occurring in roughly 3 percent of patients.24PubMed. Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors Because this damage can appear years after treatment ends, long-term vascular surveillance is part of follow-up care for childhood brain tumor survivors.
How Narrowing Is Detected
Doctors have several imaging tools for evaluating brain artery narrowing, and the choice depends on which vessels are suspected and how much detail is needed. Ultrasound of the carotid arteries in the neck is often the first screening step because it is quick, noninvasive, and inexpensive. If narrowing is found or suspected, CT angiography or MR angiography is typically used for confirmation and to get a broader look at the intracranial circulation.25PubMed Central. Imaging modalities to diagnose carotid artery stenosis: progress and prospect
Newer high-field MRI scanners can visualize much smaller intracranial vessels than older machines, and adding contrast dye extends their reach to even more distal branches.26PubMed Central. Clinical vascular imaging in the brain at 7T One of the more exciting developments is vessel wall imaging, a specialized MRI technique that looks at the artery wall itself rather than just the lumen. Different diseases leave different fingerprints on the vessel wall. Atherosclerotic plaques tend to produce focal, eccentric wall thickening, while inflammatory vasculitis typically shows concentric wall enhancement, and dissections have their own distinct appearance with a visible flap.27PubMed. Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI These patterns can help clinicians figure out why an artery is narrowed, not just that it is.
The brain also compensates for narrowed arteries through a process called remodeling, in which the artery wall expands outward to maintain the internal channel size even as plaque grows. This means a vessel can harbor substantial disease without appearing narrowed on a standard angiogram. One study found that positive (outward) remodeling was modestly associated with downstream stroke risk even after accounting for plaque size.28Stroke. Patterns and Implications of Intracranial Arterial Remodeling in Stroke Patients
Treatment Approaches
Treatment depends entirely on the underlying cause. For atherosclerotic narrowing, the first-line approach is aggressive medical management: controlling blood pressure, driving LDL cholesterol below 70 mg/dL with high-intensity statins (adding other lipid-lowering drugs if needed), managing blood sugar, and using antithrombotic medications.29Stroke. Optimal Medical Management of Atherosclerotic Intracranial Stenosis These measures are straightforward in concept but hard to maintain, and intracranial stenosis has proven stubborn even with good medical compliance.30PubMed Central. Treatment for intracranial cerebral artery stenosis
When medications are not enough, interventional options include stenting (placing a small metal scaffold inside the artery to prop it open) and surgical bypass (rerouting blood around the blockage). Early stenting results in selected patients have been promising. In one series treating symptomatic basilar artery stenosis, stent placement reduced average stenosis from about 71 percent to about 10 percent with no deaths or major complications.31Stroke. Elective Stenting of Symptomatic Basilar Artery Stenosis However, intracranial stenting carries real risks, and larger trials have shown that for many patients the complications of stenting outweigh the benefits compared with medical therapy alone. A staged approach, performing balloon angioplasty first and placing a stent later, may reduce the embolic risks of trying to cross a very tight narrowing with a bulky device.32Journal of Neurosurgery. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis
For moyamoya disease, surgical revascularization is the mainstay because no medication can halt the progressive arterial narrowing. The goal of surgery is to establish new routes for blood to reach the brain, either by directly connecting an external artery to a brain artery or by laying blood-supply-rich tissue against the brain surface and allowing new vessels to grow in over time.
Inflammatory causes such as vasculitis and autoimmune-related narrowing call for immunosuppressive therapy. Lupus-related cerebral vasculitis, for example, has responded to cyclophosphamide.18Lupus. Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide Infection-driven vasculitis requires treating the underlying infection, usually with antiviral or antimicrobial therapy, sometimes combined with corticosteroids to calm the inflammatory damage. RCVS, because it resolves on its own, is mainly managed by removing the trigger (stopping the offending drug), treating symptoms, and monitoring for complications.
Why Identifying the Cause Matters So Much
Many of these conditions look alike on a standard angiogram: all you see is a narrowed artery. But the treatment for atherosclerotic narrowing (statins, blood thinners) is completely different from the treatment for vasculitis (immunosuppression), which is different from the treatment for moyamoya (surgery), which is different from the approach to RCVS (removing the trigger and waiting). Misidentifying the cause can mean prescribing the wrong therapy or missing a treatable condition entirely. The lupus case reports described earlier illustrate this well. Initial narrowing was attributed to atherosclerosis; only after a second round of strokes and specialized vessel wall imaging was the true inflammatory cause uncovered.17PubMed Central. A case of systemic lupus erythematosus associated with cerebral arteritis: a case report and case-based literature review
If you or someone you know has been told about narrowed brain arteries, the single most important question to push on is “why.” An atherosclerotic plaque in a 70-year-old with high cholesterol and a vasculitic lesion in a 35-year-old with lupus may produce the same spot on an angiogram, but they are fundamentally different diseases with fundamentally different trajectories. Getting the diagnosis right is what makes effective treatment possible.